IRIS ATROPHY

This adverse event was reported 207 times

These drugs are most commonly taken by patients reporting IRIS ATROPHY:

# Drug Count
0 MELPHALAN HYDROCHLORIDE 42
1 CARBOPLATIN 24
2 ETOPOSIDE 23
3 MOXIFLOXACIN HYDROCHLORIDE 21
4 LATANOPROST 16
5 TOPOTECAN 12
6 DEXAMETHASONE 10
7 DEXAMETHASONE 1.5 MG 10
8 MOXIFLOXACIN 10
9 PREDNISOLONE ACETATE 9
See all common drugs associated with IRIS ATROPHY

IRIS ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACETYLCHOLINE CHLORIDE 4 0.0408
1 TETRACAINE HYDROCHLORIDE 3 0.0226
2 BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE 1 0.0027
3 SODIUM HYALURONATE 2 0.0024
4 NEPAFENAC 7 0.0022
5 TOPOTECAN HYDROCHLORIDE 5 0.0021
6 TOPOTECAN 12 0.0020
7 MELPHALAN HYDROCHLORIDE 42 0.0017
8 BALANCED SALT SOLUTION 2 0.0015
9 HYALURONATE SODIUM 2 0.0013
See all drugs enriched for association with IRIS ATROPHY

IRIS ATROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 5 0.0011
1 Topoisomerase Inhibitor [EPC] 35 0.0005
2 Plasma Volume Expander [EPC] 1 0.0003
3 Prostaglandin Analog [EPC] 22 0.0002
4 Quinolone Antimicrobial [EPC] 2 0.0002
5 Osmotic Diuretic [EPC] 1 0.0002
6 Anticholinergic [EPC] 3 0.0002
7 Carbonic Anhydrase Inhibitor [EPC] 3 0.0001
8 Dipeptidyl Peptidase 4 Inhibitor [EPC] 4 0.0001
9 Ester Local Anesthetic [EPC] 5 0.0001
See all drug classes enriched for association with IRIS ATROPHY